{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:02Z","timestamp":1759056902039},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T00:00:00Z","timestamp":1256256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2377-9-56","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T14:13:36Z","timestamp":1256307216000},"source":"Crossref","is-referenced-by-count":9,"title":["Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Zeljka","family":"Petelin Gadze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Hajnsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Basic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Sporis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Pavlisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibila","family":"Nankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,23]]},"reference":[{"issue":"10","key":"270_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66 (10): 1485-9. 10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"issue":"1","key":"270_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","volume":"10","author":"DM Wingerchuk","year":"2008","unstructured":"Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Curr Treat Options Neurol. 2008, 10 (1): 55-66. 10.1007\/s11940-008-0007-z.","journal-title":"Curr Treat Options Neurol"},{"issue":"9451","key":"270_CR3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364 (9451): 2106-12. 10.1016\/S0140-6736(04)17551-X.","journal-title":"Lancet"},{"issue":"2","key":"270_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","volume":"71","author":"A McKeon","year":"2008","unstructured":"McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ: CNS aquaporin-4 autoimmunity in children. Neurology. 2008, 71 (2): 93-100. 10.1212\/01.wnl.0000314832.24682.c6.","journal-title":"Neurology"},{"key":"270_CR5","first-page":"243","volume-title":"Multiple Sclerosis","author":"DM Wingerchuk","year":"2003","unstructured":"Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Multiple Sclerosis. Edited by: McDonald WI, Noseworthy JH. 2003, Woburn, MA: Butterworth-Heinemann, 243-58. 2","edition":"2"},{"issue":"3","key":"270_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG: Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006, 63 (3): 390-6. 10.1001\/archneur.63.3.390.","journal-title":"Arch Neurol"},{"key":"270_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y: Anti-aquaporin 4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007, 130: 1235-43. 10.1093\/brain\/awm062.","journal-title":"Brain"},{"issue":"9","key":"270_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6 (9): 805-15. 10.1016\/S1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"key":"270_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.nrl.0000250927.21903.f8","volume":"13","author":"DM Wingerchuck","year":"2007","unstructured":"Wingerchuck DM: Diagnosis and Treatment of Neuromyelitis Optica. Neurologist. 2007, 13: 2-11. 10.1097\/01.nrl.0000250927.21903.f8.","journal-title":"Neurologist"},{"key":"270_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuck","year":"1999","unstructured":"Wingerchuck DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999, 53: 1107-14.","journal-title":"Neurology"},{"key":"270_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","author":"RN Mandler","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE: Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998, 51: 1219-20.","journal-title":"Neurology"},{"issue":"7","key":"270_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ncprheum0818","volume":"4","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Kerr D: Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2008, 4 (7): 381-6.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"270_CR13","first-page":"136","volume":"40","author":"RM Feingold","year":"2008","unstructured":"Feingold RM: Neuromyelitis optica. J Insur Med. 2008, 40 (2): 136-40.","journal-title":"J Insur Med"},{"issue":"11","key":"270_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","volume":"65","author":"A Jacob","year":"2008","unstructured":"Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA: Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008, 65 (11): 1443-8. 10.1001\/archneur.65.11.noc80069.","journal-title":"Arch Neurol"},{"key":"270_CR15","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W: Antibody to aquaporin 4 in the long-term course of neuromyelitis optica. Brain. 2008, 131: 3072-80. 10.1093\/brain\/awn240.","journal-title":"Brain"},{"issue":"2","key":"270_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00115-008-2663-3","volume":"80","author":"A Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der A, Ellrichmann G, Chehab G, Schneider M, Linker RA, Gold R: Rituximab in treatment for neuroimmunological diseases. Nervenarzt. 2009, 80 (2): 155-65. 10.1007\/s00115-008-2663-3.","journal-title":"Nervenarzt"},{"issue":"1","key":"270_CR17","first-page":"172","volume":"35","author":"CC Mok","year":"2008","unstructured":"Mok CC, To CH, Mak A, Poon WL: Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica. J Rheumatol. 2008, 35 (1): 172-4.","journal-title":"J Rheumatol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-9-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-9-56\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-9-56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:16:56Z","timestamp":1558592216000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-9-56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,23]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-9-56","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,23]]},"article-number":"56"}}